Gedeon Richter: an innovative, research and development-driven speciality pharmaceutical company
'Gedeon Richter's goal is to help the public fight illness with innovative pharmaceutical products and, by doing so, help improve the quality of human life.'
The company was founded in 1901 by Hungarian pharmacist Gedeon Richter. Today Richter has grown to become a multinational pharmaceutical company with headquarters in Budapest. The company's products are distributed in more than 100 countries and it employs around 11,000 people worldwide.
Innovation and the research of original drug molecules have always been key elements in the Company's strategy. With 1000 employees in the field of research and development, Richter's main areas of focus are the treatment of benign gynaecological conditions and diseases of the central nervous system.
The Women's Health Division of Richter is dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine. The company is one of very few in the world to offer a comprehensive portfolio of products for gynaecological conditions.
R&D activities within Women's Health focus on developing non-invasive medical treatments for common gynaecological conditions which are currently under-treated. Many of these conditions can have a severe impact on the patient's quality of life. The company has a pipeline of innovative compounds which includes several first in class molecules with development stages spanning from pre-clinical to newly licensed.
Gedeon Richter Global website – www.richter.hu
Gedeon Richter have been operating in the UK for over 60 years under the name Medimpex UK. In 2012 Gedeon Richter launched a Women's Health Division and now both Medimpex UK and the Women’s Health Division of Gedeon Richter are based in Maida Vale, London.